CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on November 14, 2007
Clinical Journal of the American Society of Nephrology
© 2007 American Society of Nephrology
doi: 10.2215/CJN.03280807
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.03280807v1
3/1/46    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y. E.

Received August 7, 2007
Accepted on September 12, 2007

ORIGINAL ARTICLES

Value of a Complete or Partial Remission in Severe Lupus Nephritis

Yiann E. Chen *, Stephen M. Korbet *1, Robert S. Katz *, Melvin M. Schwartz {dagger}, Edmund J. Lewis *, and for the Collaborative Study Group

Departments of *Medicine, and {dagger}Pathology, Rush University Medical Center, Chicago, Illinois


Departments, of *Medicine, and {dagger}Pathology, Rush University Medical Center, Chicago, Illinois


1 To whom correspondence should be addressed. E-mail: skorbet{at}aol.com.


   Abstract

Background and objectives: The value of a complete remission in severe lupus nephritis is well known but little is known about the impact of a partial remission in this patient population. The purpose of this study was to evaluate the long-term prognosis of achieving a complete or partial remission in a well-defined group of patients with severe lupus nephritis.

Design, setting, participants, & measurements: In this study, 86 patients with diffuse lupus glomerulonephritis were reviewed for assessment of the value of a partial remission (50% reduction in baseline proteinuria to ≤1.5 g/d and ≤25% increase in baseline creatinine) and complete remission (proteinuria ≤0.33 g/d and serum creatinine ≤1.4 mg/dl) on outcomes compared with patients who did not attain a remission. These well-characterized patients were entered into a prospective therapeutic trial conducted by the Collaborative Study Group and were followed for more than 10 yr.

Results: All biopsies showed diffuse lupus nephritis. A complete remission was attained in 37 (43%) patients, a partial remission in 21 (24%) patients, and no remission in 28 (32%) patients. Baseline clinical and serologic features were similar among the groups, but patients with a complete remission had a lower serum creatinine and chronicity index compared with patients with partial or no remission. The patient survival at 10 yr was 95% for complete remission, 76% for partial remission, and 46% for no remission. The renal survival at 10 yr was 94% for complete remission, 45% for partial remission, and 19% for no remission, and the patient survival without end-stage renal disease at 10 yr was 92% for complete remission, 43% for partial remission, and 13% for no remission.

Conclusion: Even a partial remission in lupus nephritis is associated with a significantly better patient and renal survival compared with no remission.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
M. I. Danila, G. J. Pons-Estel, J. Zhang, L. M. Vila, J. D. Reveille, and G. S. Alarcon
Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort
Rheumatology, May 1, 2009; 48(5): 542 - 545.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
P. M. Izmirly, L. Barisoni, J. P. Buyon, M. Y. Kim, T. L. Rivera, J. S. Schwartzman, J. M. Weisstuch, D. T. Liu, S. Bernstein, C.-E. Tseng, et al.
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis
Rheumatology, May 1, 2009; 48(5): 513 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. J. Glassock
Multitarget Therapy of Lupus Nephritis: Base Hit or Home Run?
J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1842 - 1844.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society of Nephrology.